催眠神经刺激和阻塞性睡眠呼吸暂停患者的心血管结果:一项随机临床试验
Raj C Dedhia1,2, Donald L Bliwise3, Arshed A Quyyumi4
1Department of Otorhinolaryngology, University of Pennsylvania, Philadelphia.
JAMA otolaryngology-- head & neck surgery
|November 30, 2023
概括
在患有阻塞性睡眠呼吸暂停 (OSA) 的患者中,低分泌神经刺激 (HGNS) 疗法没有显著改变心血管指标,如血压. 未来的试验应该纳入从这个假控制研究中学到的经验教训.
科学领域:
- 心血管医学 心血管医学
- 睡眠医学 睡眠医学
- 医疗器械 医疗器械
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 与心血管并发症有关.
- 低音神经刺激 (HGNS) 是适度至重度OSA的治疗方法.
- HGNS对心血管的影响需要通过假控制试验进行进一步的调查.
研究的目的:
- 评估治疗性HGNS与假药治疗对OSA患者血压,同情活动和血管功能的影响.
- 为了在随机交叉试验中比较活跃和假冒的HGNS疗法之间的心血管终点.
主要方法:
- 一个双盲,假控制,随机交叉试验,涉及60名成年OSA患者,植入了HGNS设备.
- 参与者接受了4周的活跃HGNS和4周的假HGNS治疗.
- 主要结局是24小时缩血压的变化;次要结局包括排泄前期 (PEP) 和流量介导扩张 (FMD).
主要成果:
- 在主动和假的HGNS治疗之间,没有发现平均24小时缩血压的显著差异.
- 预喷射期 (PEP) 和流媒体扩张 (FMD) 也显示两种治疗臂之间没有显著差异.
- 每个协议的分析表明,在一个具有显著的呼吸暂停-呼吸暂停指数减少的子组中,存在潜在的差异.
结论:
- 这项随机临床试验在OSA患者的活性和虚假HGNS治疗之间没有发现心血管指标的显著差异.
- 获得了方法学的见解,以指导未来的HGNS随机临床试验.
- 需要进一步的研究才能充分理解HGNS治疗对心血管的影响.
相关概念视频
Sleep Apnea
159
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
159
Hyperpnea and Hyperventilation
1.1K
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
1.1K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
839
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
839


